The European Medicines Agency (EMA) has relocated from London to the Spark building in Amsterdam Sloterdijk. This is a temporary accommodation. Later this year, the Agency will relocate to a new building on the Zuidas in Amsterdam. The information on this website is intended for anyone interested in the ins and outs of the relocation.
The role of the CHMP in the introduction of medicines
25-03-2019 | 08:07
The committee for the evaluation of medicinal products for human use advises on the authorization of medicinal products. How does ...
European Commissioner Andriukaitis visits EMA in Amsterdam
20-03-2019 | 00:00
On Tuesday the 19th of March Vytenis Andriukaitis, European Commissioner for Health and Food safety visited the EMA in her new ...
How do you 'monitor' medicines?
12-03-2019 | 00:00
What does the European Pharmacovigilance Risk Assessment Committee do? Sabine Straus is chairman of this committee and informs us ...